Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 163
Filter
1.
Rev. Fac. Cienc. Méd. (Quito) ; 49(2): 50-58, Mayo 27, 2024.
Article in Spanish | LILACS | ID: biblio-1556302

ABSTRACT

Introducción: El cáncer de mama masculino es una patología infrecuente que re-presenta menos del 1% de la patología mamaria maligna, con una edad media de diagnóstico de 67 años. Tiene un peor pronóstico que el cáncer de mama femenino debido a su alto origen genético y baja sospecha, desencadenando diagnósticos inadecuados y tardíos, y disminuyendo la supervivencia a mediano y largo plazo.Objetivo: Describir el caso clínico de un paciente masculino con diagnóstico de cáncer de mama, abordando la presentación clínica, los métodos diagnósticos, el tratamiento oncoespecífico, y la evolución clínica y quirúrgica. Presentación del caso: Se presenta un paciente masculino de 52 años, con evi-dencia de lesión exofítica en mama derecha más ganglio axilar ipsilateral, con diag-nóstico confirmado de patología de cáncer de mama estadio clínico cT4bN1Mx. Se plantea un manejo multidisciplinario: quimioterapia neoadyuvante y mastecto-mía radical derecha. Finalmente recibe tratamiento oncoespecífico y radioterapia con evolución favorable.Discusión: El cáncer de mama masculino tiene una baja incidencia respecto a la mujer, por lo que su sospecha diagnóstica se ve limitada. En etapas iniciales el diagnóstico es inespecífico debido a las pocas manifestaciones clínicas, pero deberá respaldarse en métodos imagenológicos, análisis anatomopatológico e in-munohistoquímico para guiar el tratamiento oncoespecífico.Conclusión: El cáncer de mama masculino posee una sospecha diagnóstica limi-tada que requiere un manejo multidisciplinario específico. La correcta estadifica-ción de la patología depende del seguimiento clínico y un análisis inmunohistoquí-mico oportuno, para un tratamiento adecuado con mejores resultados clínicos y altas tasas de supervivencia.


Introduction: Male breast cancer is an infrequent pathology; it represents less than 1% of malignant breast pathology, with an average age of diagnosis of 67 years. It has a worse prognosis than female breast cancer, due to its high genetic origin and low suspicion, which leads to inadequate and late diagnosis, becoming evident in advanced stages, decreasing survival in the medium and long term.Objective: To describe the clinical case of a patient diagnosed with breast cancer, addressing the clinical presentation, diagnostic methods, oncospecific treatment, as well as the corresponding clinical and surgical evolution.Case presentation: We present a 52-year-old male patient, with evidence of exophytic lesion in right breast plus ipsilateral axillary node, with diagnosis confir-med by pathology report of breast cancer, clinical stage: cT4bN1Mx. A multidisci-plinary management is proposed, initially the patient receives neoadjuvant chemo-therapy, then undergoes a surgical procedure: radical right mastectomy. Finally, she receives oncospecific treatment in the specialties of clinical oncology and radiothe-rapy, with favorable evolution.Discussion: Male breast cancer has a low incidence compared to women, so its diagnostic suspicion is limited. In initial stages the diagnosis is unspecific due to the few clinical manifestations, but should be supported by imaging methods and confirmatory methods, an anatomopathological and immunohistochemical analy-sis, to guide oncospecific treatment. Conclusions: Male breast cancer, is an infrequent pathology with limited diagnos-tic suspicion, which requires specific multidisciplinary management. It is important to have a continuous medical follow-up of the patient, to achieve at the time of diagnosis a correct clinical and immunohistochemical staging, which allows to fo-cus on the appropriate management and treatment, with better clinical outcomes and better survival rates.


Subject(s)
Humans , Male , Middle Aged , Mastectomy, Radical , Men , Breast Neoplasms/diagnosis , Medical Oncology
2.
Psicol. ciênc. prof ; 44: e263084, 2024. tab
Article in Portuguese | LILACS, INDEXPSI | ID: biblio-1564971

ABSTRACT

O objetivo deste estudo foi investigar os efeitos terapêuticos da Psicoterapia Breve Operacionalizada (PBO) na adaptação de mulheres diagnosticadas com câncer de mama e em tratamento oncológico. O câncer de mama mostra-se mobilizador de sofrimento psíquico para as mulheres tanto no diagnóstico quanto no tratamento, o que justifica identificar intervenções psicológicas adequadas para essa população. As participantes foram 17 mulheres com idade entre 30 e 65 anos. A Escala Diagnóstica Adaptativa Operacionalizada (EDAO) foi o instrumento utilizado para avaliação da adaptação em quatro setores: afetivo-relacional, produtividade, orgânico e sociocultural. Referida avaliação foi feita em três momentos: antes e após a intervenção breve, e no follow-up . A PBO foi a intervenção breve utilizada. Os resultados mostraram que o setor orgânico foi o mais comprometido, seguido do afetivo-relacional, com soluções pouquíssimo adequadas. Como foco da psicoterapia breve, a situação-problema mais recorrente se relacionava ao câncer de mama, que, na compreensão psicodinâmica, mostrou-se associada ao intenso desamparo egóico diante do adoecimento e tratamento oncológico. Na avaliação adaptativa final e follow-up , 82,4% das participantes apresentaram evolução de grupo adaptativo. Concluímos que, neste estudo, a intervenção com a PBO possibilitou efeitos terapêuticos na adaptação, reverberando na solução das situações-problema e na crise adaptativa por perda.(AU)


This study aimed to investigate the therapeutic effects of Operationalized Brief Psychotherapy (PBO) so women diagnosed with breast cancer could adapt to treatment. Breast cancer has mobilized psychological suffering for women during diagnosis and treatment, justifying the identification of the appropriate psychological interventions for this population. Participants included 17 women aged 30 to 65 years. Adaptative Operational Diagnostic Scale (EDAO) was used to evaluated adaptation in four sectors: affective-relational, productivity, organic, and sociocultural before and after a brief psychological intervention and follow-up. The PBO was used as the brief intervention. Results showed that the organic sector was the most compromised, followed by the affective-relational one, which showed very little adequate solutions. As a focus of brief psychotherapy, the most recurring problem-situation was related to breast cancer, which, in yjr psychodynamic understanding, was associated with the intense helplessness of the ego in the face of illness and treatment. In the final adaptative evaluation and follow-up, 82.4% of participants showed evolution in the adaptive group. This study concluded that the intervention with PBO enabled therapeutic effects in these participants' adaptation, reverberating in the solution of problem-situation and in the adaptive crisis by loss.(AU)


El propósito de este estudio fue investigar los efectos terapéuticos de la psicoterapia breve operacionalizada (PBO) en la adaptación de mujeres diagnosticadas con cáncer de mama y en tratamiento oncológico. El cáncer de mama moviliza sufrimiento psicológico para las mujeres tanto en el diagnóstico como en el tratamiento, lo que justifica identificar intervenciones psicológicas adecuadas para esta población. Participaron 17 mujeres de entre 30 y 65 años. El instrumento utilizado fue la Escala de Diagnóstico Adaptativo Operacionalizada (EDAO) para la evaluación adaptativa en cuatro sectores: afectivo-relacional, productividad, orgánico y sociocultural. La evaluación se realizó en tres momentos: antes, después de la intervención breve y en el seguimiento. La PBO fue la intervención breve utilizada. Los resultados mostraron que el sector orgánico fue el más comprometido, seguido por el afectivo-relacional con soluciones poquísimas adecuadas. Como foco de la psicoterapia breve, la situación-problema más recurrente estuvo relacionada con el cáncer de mama, que en la comprensión psicodinámica resultó estar asociada a un intenso desamparo ante la enfermedad y el tratamiento oncológico. En la evaluación adaptativa final y el seguimiento, el 82,4% de las participantes tuvieron evolución grupal adaptativa. Se concluye que la intervención con PBO permitió efectos terapéuticos en la adaptación de estos participantes, repercutiendo en la solución de situaciones-problema y en la crisis adaptativa por pérdida.(AU)


Subject(s)
Humans , Female , Adult , Middle Aged , Aged , Psychotherapy, Brief , Breast Neoplasms , Health , Diagnosis , Anxiety , Pain , Psychology , Recurrence , Rehabilitation , Shame , Solutions , Surgical Procedures, Operative , Therapeutics , Women , Bereavement , Adaptation, Psychological , Mastectomy, Radical , Homeopathic Cure , Disease , Follow-Up Studies , Aftercare , Life , Crisis Intervention , Death , Comprehension , Therapeutic Uses , Depression , Drug Therapy , Drug-Related Side Effects and Adverse Reactions , Efficiency , Fear , Return to Work , Physical Appearance, Body , Sadness , Psychological Distress , Psychological Well-Being , Lymph Node Excision , Medical Oncology
3.
Rev. cuba. cir ; 62(1)mar. 2023.
Article in Spanish | LILACS, CUMED | ID: biblio-1521878

ABSTRACT

Introducción: El cáncer ha causado más muertes que todas las guerras y catástrofes conocidas. En particular, el cáncer de mama se ha convertido en una pandemia que amenaza con seguir propagándose. Objetivo: Describir las diferencias en cuanto a los resultados obtenidos de la cirugía conservadora y radical como tratamiento del cáncer de mama. Métodos: Se realizó un estudio analítico, observacional, descriptivo y retrospectivo en un universo de 177 pacientes con diagnóstico de cáncer de mama en el servicio de Cirugía General del Centro de Investigaciones Médico Quirúrgicas de La Habana, Cuba. Todas recibieron tratamiento quirúrgico en el período comprendido de enero de 2011 a diciembre de 2016. Resultados: De las pacientes estudiadas, el 92,09 por ciento no presentaron antecedentes de patología mamaria, mientras que el 36,72 por ciento tuvieron como antecedente patológico familiar cáncer de mama. Predominaron las pacientes mayores de 70 años en ambas técnicas quirúrgicas. En el grupo de 30-40 años solamente se practicaron técnicas conservadoras. Con respecto al estadiamiento, predominó la etapa II de la enfermedad. La sobrevida global a los 5 años fue superior al 90 por ciento, mientras que el intervalo libre de enfermedad se mantuvo en valores similares para ambas técnicas. Conclusiones: Se realizaron mayor número de cirugías conservadoras de mama en pacientes que se encontraban en etapas clínicas más tempranas de la enfermedad y la sobrevida global de los procedimientos conservadores fue ligeramente mayor(AU)


Introduction: Cancer has caused more deaths than all known wars and catastrophes. Particularly speaking, breast cancer has become a pandemic that threatens to continue to spread. Objective: To describe the differences based on the results obtained from conservative and radical surgery as a treatment for breast cancer. Methods: An analytical, observational, descriptive and retrospective study was carried out with a universe of 177 female patients diagnosed with breast cancer in the general surgery service of Centro de Investigaciones Médico Quirúrgicas, of La Habana, Cuba. All of them received surgical treatment in the period from January 2011 to December 2016. Results: 92.09 percent of the patients studied had no history of breast pathology, while 36.72 percent had breast cancer as a family pathological history. Patients over 70 years of age predominated in both surgical techniques. In the group of 30-40 years of age only conservative techniques were performed. With respect to staging, there was a predominance of the disease in stage II. Overall survival at 5 years was higher than 90 percent, while the disease-free interval remained at similar values for both techniques. Conclusions: A greater amount of breast-conserving surgeries were performed in patients at earlier clinical stages of the disease, while overall survival of conservative procedures was slightly higher(AU)


Subject(s)
Humans , Female , Adult , Aged , Breast Neoplasms/epidemiology , Mastectomy, Radical , Epidemiology, Descriptive , Observational Studies as Topic
4.
Rev. bras. cancerol ; 67(1): e-061156, 2021.
Article in Portuguese | LILACS | ID: biblio-1147359

ABSTRACT

Introdução: A eritrodermia esfoliativa é um evento raro que está associado a diversas doenças como psoríase, eczemas, neoplasias malignas, uso de medicamentos, entre outras. Relato do caso: Paciente de 63 anos apresentou quadro de exantema difuso iniciado em janeiro de 2018, evoluindo com descamação generalizada da pele e formação de úlceras, sentindo calafrios. Não referiu histórico de câncer na família. Na anamnese, não houve relato de nenhum tipo de eczema, doença de pele preexistente ou uso de plantas medicinais. Foi identificada neoplasia maligna de mama do subtipo molecular luminal A, posteriormente. Após mastectomia com linfadenectomia, houve apenas melhora parcial do quadro da eritrodermia. Atualmente, em uso de doxorrubicina. Conclusão: A paciente apresentou quadro clínico inicial condizente com o que se espera de eritrodermia, que pode estar associada ao surgimento de neoplasia maligna de mama. O presente relato é importante, pois pode auxiliar em diagnósticos diferenciais para a eritrodermia, mesmo na vigência de um quadro clínico atípico.


Introduction: Exfoliative erythroderma is a rare event associated with several diseases such as psoriasis, eczema, malignant neoplasms, medication use, among others. Case report: A 63-year-old patient presented diffuse rash that started in January 2018, evolving with generalized skin desquamation and ulcer formation, with chills. Did not report family history of cancer. In the anamnesis, there was no report of any type of eczema, preexisting skin disease or use of medicinal plants. Malignant breast cancer of luminal A molecular subtype was identified later. After mastectomy with lymphadenectomy, there was only partial improvement in erythroderma. Currently using doxorubicin. Conclusion: The patient presented an initial clinical condition consistent with what is expected from erythroderma, which may be associated with the emergence of malignant breast neoplasm. The present report is important because it can help in differential diagnoses for erythroderma, even in the presence of an atypical clinical case.


Introducción: La eritrodermia exfoliativa es un evento raro asociado con varias enfermedades como psoriasis, eccema, neoplasmas malignos, uso de medicamentos, entre otros. Relato del caso: Paciente de 63 años presentó una erupción cutánea difusa que comenzó en enero de 2018, que evolucionó con descamación generalizada de la piel y formación de úlceras, con escalofríos. No informó antecedentes familiares de cáncer. En la anamnesis, no hubo informes de ningún tipos de eccema, enfermedad cutánea preexistente o uso de plantas medicinales. La neoplasia de mama maligna del subtipo molecular luminal A se identificó más tarde. Después de la mastectomía con linfadenectomía, solo hubo una mejoría parcial en la eritrodermia. Actualmente usa doxorrubicina. Conclusión: La paciente presentó un cuadro clínico inicial consistente con lo que se espera de la eritrodermia, que puede estar asociada con la aparición de neoplasma maligno de mama. El presente informe es importante porque puede ayudar en los diagnósticos diferenciales de eritrodermia, incluso en presencia de un cuadro clínico atípico.


Subject(s)
Humans , Female , Middle Aged , Breast Neoplasms , Dermatitis, Exfoliative , Mastectomy, Radical
5.
Article in English | WPRIM | ID: wpr-759529

ABSTRACT

BACKGROUND: The breast is innervated by the intercostal nerves and the brachial plexus. We propose a technique to perform breast surgery without general anesthesia using the erector spinae plane (ESP) block and selective block of four nerves that arise from the brachial plexus innervate the breast and the axilla (SBP block). CASE: A 77-year-old man with breast cancer was scheduled for radical mastectomy and axillary clearance. He had a previous history of myocardial infarction with dilated cardiomyopathy and severely impaired ejection fraction. The surgery was performed under regional anesthesia with combined ESP and SBP block. The patient did not require opioids or other supplemental analgesics intra- or postoperatively and was discharged uneventfully. CONCLUSIONS: SBP is a novel block that selectively blocks branches of the brachial plexus that innervate the breast.


Subject(s)
Aged , Humans , Analgesics , Analgesics, Opioid , Anesthesia, Conduction , Anesthesia, General , Axilla , Brachial Plexus Block , Brachial Plexus , Breast Neoplasms , Breast , Cardiomyopathy, Dilated , Intercostal Nerves , Mastectomy, Radical , Myocardial Infarction
6.
Rev. bras. cir. plást ; 33(1): 3-11, jan.-mar. 2018. tab, ilus
Article in English, Portuguese | LILACS | ID: biblio-883627

ABSTRACT

Introdução: O objetivo do trabalho foi avaliar as principais características e métodos utilizados na reconstrução mamária de mulheres jovens, considerando suas peculiaridades. Métodos: Foi realizada uma revisão retrospectiva dos prontuários das pacientes submetidas à mastectomia seguida de reconstrução mamária no período de janeiro de 2008 a dezembro de 2015, sendo selecionados aqueles cuja reconstrução foi realizada em mulheres de até 40 anos de idade. Resultados: 43 pacientes foram selecionadas. A média de idade foi de 33,86 anos. Grande parte possuía alguma comorbidade, sendo as mais comuns o sobrepeso e o transtorno ansioso/depressivo. Quatorze pacientes tinham história familiar da doença. A maioria obteve o diagnóstico de carcinoma ductal invasor. Tratamentos oncológicos complementares foram realizados em grande parte dos casos. Todas as pacientes foram submetidas à mastectomia total na mama portadora da neoplasia, sendo que em 16 houve a opção pela mastectomia redutora de risco contralateral. Do total de 43 reconstruções, 36 foram imediatas e 7 tardias; sendo 17 reconstruídos com implantes mamários, 13 com expansores teciduais, 4 com TRAM e 9 com GD. Houve 15 complicações, sendo as mais graves um caso de infecção com perda da reconstrução e um caso de necrose de aréola. Conclusões: Mulheres jovens submetidas à reconstrução mamária representam um subgrupo populacional com características próprias. Os padrões tumorais, pessoais e sociais diferem e, com base nesta imensa lista de variáveis, as possibilidades de tratamento são diversas. Em nossa casuística, o emprego de implantes mamários e expansores teciduais foi realizado com maior frequência neste subgrupo de pacientes.


Introduction: To evaluate the main features and methods used in breast reconstruction in young women considering their unique characteristics. Methods: A retrospective records review of patients who underwent mastectomy followed by breast reconstruction between January 2008 and December 2015 was conducted, selecting those reconstructions that were performed in women younger than 40 years. Results: Forty-three patients were selected. The average age was 33.86 years. Many had some comorbidities, the most common being overweight and anxiety/ depressive disorder. Fourteen patients had a family history of the disease. Most were diagnosed with invasive ductal carcinoma. Additional cancer treatments were administered in most cases. All patients underwent a full mastectomy in the breast with cancer, and in 16, there was the option of contralateral risk-reducing mastectomy. Of the 43 reconstructions, 36 were immediate and 7 were delayed, and 17 involved use of implants, 13 involved use of tissue expanders, 4 involved the TRAM, and 9 involved the GD. We observed 15 complications; the most severe were infection with reconstruction loss in one patient and areola necrosis in another. Conclusions: Young women undergoing breast reconstruction represent a population subgroup with its own characteristics. The tumors and personal and social patterns differ, and based on this long list of variables, treatment options are diverse. In our series, breast implants and tissue expanders were often most used.


Subject(s)
Humans , Female , Adult , Middle Aged , Aged , History, 21st Century , Postoperative Complications , Breast , Breast Neoplasms , Mastectomy, Radical , Retrospective Studies , Mammaplasty , Plastic Surgery Procedures , Young Adult , Mastectomy , Postoperative Complications/surgery , Postoperative Complications/rehabilitation , Breast/surgery , Breast Neoplasms/surgery , Breast Neoplasms/complications , Breast Neoplasms/therapy , Mastectomy, Radical/adverse effects , Mastectomy, Radical/methods , Mastectomy, Radical/rehabilitation , Mammaplasty/adverse effects , Mammaplasty/methods , Mammaplasty/rehabilitation , Plastic Surgery Procedures/adverse effects , Plastic Surgery Procedures/methods , Plastic Surgery Procedures/rehabilitation , Young Adult/statistics & numerical data , Mastectomy/adverse effects , Mastectomy/methods
7.
Article in English | WPRIM | ID: wpr-713697

ABSTRACT

PURPOSE: Five members of the zinc finger of the cerebellum (ZIC) family—ZIC1, ZIC2, ZIC3, ZIC4, and ZIC5—have been shown to be involved in various carcinomas. Here, we aimed to explore the clinicopathologic and prognostic roles of ZIC family members in invasive breast cancer patients using immunohistochemical analysis, western blotting analysis, and real-time quantitative polymerase chain reaction (RT-qPCR). METHODS: A total of 241 female invasive breast cancer patients who underwent radical mastectomy between 2009 and 2011 were enrolled. ZIC proteins in 241 pairs of breast tumors and corresponding normal tissues were investigated using immunohistochemistry and the clinicopathologic roles of proteins were analyzed using Pearson's chi-square test. Kaplan-Meier curves and Cox regression analysis were also used to analyze the prognostic value of the ZIC proteins. In addition, 12 pairs of fresh-frozen breast tumors and matched normal tissues were used in the western blotting analysis and RT-qPCR. RESULTS: Only ZIC1 expression in normal tissues was obviously higher than that in tumors (p < 0.001). On multivariate analysis, ZIC1 expression (in overall survival analysis: hazard ratio [HR], 0.405, 95% confidence interval [CI], 0.233–0.702, p=0.001; in disease-free survival analysis: HR, 0.395, 95% CI, 0.234–0.669, p=0.001) was identified as a prognostic indicator of invasive breast cancer. CONCLUSION: ZIC1, but not the other proteins, was obviously decreased in breast tumors and associated with clinicopathologic factors. Thus, ZIC1 might be a novel indicator to predict the overall and disease-free survival of invasive breast cancer patients.


Subject(s)
Female , Humans , Blotting, Western , Breast Neoplasms , Breast , Cerebellum , Disease-Free Survival , Immunohistochemistry , Mastectomy, Radical , Multivariate Analysis , Pathology , Polymerase Chain Reaction , Prognosis , Zinc Fingers , Zinc
8.
Rev. bras. cancerol ; 64(4): 569-573, 2018.
Article in Portuguese | LILACS | ID: biblio-1025155

ABSTRACT

Introdução: O linfedema é a complicação mais comum após o tratamento do câncer de mama. Quando se manifesta antes do tratamento cirúrgico, como condição clínica por si só, é visto como um critério de inoperabilidade, representando um fator de mau prognóstico. Relato do caso: Este artigo visa a descrever a evolução clínica de uma paciente com linfedema de membro superior prévio à cirurgia para o câncer de mama, à condução do tratamento fisioterapêutico e à viabilidade do procedimento cirúrgico. Conclusão: Por meio deste relato de caso, foi possível descrever o tratamento fisioterapêutico de uma paciente com linfedema prévio à cirurgia para o câncer de mama. A equipe de fisioterapia pôde atuar em parceria com a equipe médica, controlando a descompensação linfática e auxiliando no caminho até a realização do procedimento cirúrgico. O cuidado fisioterapêutico se mostra fundamental desde o início do tratamento oncológico, de forma a detectar precocemente sintomas e distúrbios, intervindo de maneira eficaz e resolutiva e buscando proporcionar qualidade de vida e os melhores resultados possíveis para as pacientes.


Introduction: Lymphedema is the most common complication after breast cancer treatment. When it manifests itself before surgical treatment, as a clinical condition alone, it is seen as a criterion of inoperability, representing a factor of poor prognosis. Case report: This article aims to describe the clinical evolution of a patient with upper limb lymphedema prior to surgery for breast cancer, the conduct of the physiotherapeutic treatment and the feasibility of the surgical procedure. Conclusion: Through this case report it was possible to describe the physiotherapeutic treatment of a patient with lymphedema prior to surgery for breast cancer. The physiotherapy team can work in partnership with the medical team, controlling the lymphatic decompensation and assisting in the way until the surgical procedure is performed. Physiotherapeutic care has been fundamental since the beginning of cancer treatment, in order to detect early symptoms and disorders, intervening effectively and resolutely and seeking to provide quality of life and the best possible outcomes for patients.


Introducción: El linfedema es la complicación más común después del tratamiento del cáncer de mama. Cuando se manifiesta antes del tratamiento quirúrgico, como condición clínica por sí solo, es visto como un criterio de inoperabilidad, representando un factor de mal pronóstico. Relato del caso: En este artículo se pretende describir la evolución clínica de una paciente con linfedema de miembro superior previo a la cirugía para el cáncer de mama, la conducción del tratamiento fisioterapéutico y la viabilidad del procedimiento quirúrgico. Conclusión: A través de este relato de caso fue posible describir el tratamiento fisioterapéutico de una paciente con linfedema previo a la cirugía para el cáncer de mama. El equipo de fisioterapia puede actuar en asociación con el equipo médico, controlando la descompensación linfática y auxiliando en el camino hasta la realización del procedimiento quirúrgico. El cuidado fisioterapéutico se muestra fundamental desde el inicio del tratamiento oncológico, para detectar precozmente síntomas y disturbios, interviniendo de manera eficaz y resolutiva y buscando proporcionar calidad de vida y los mejores resultados posibles para las pacientes.


Subject(s)
Humans , Female , Middle Aged , Breast Neoplasms/complications , Physical Therapy Modalities , Breast Cancer Lymphedema/diagnosis , Mastectomy, Radical , Neoadjuvant Therapy
10.
Pakistan Journal of Medical Sciences. 2017; 33 (4): 844-848
in English | IMEMR | ID: emr-188598

ABSTRACT

Objective: To investigate the expression of Topo Ha and Ki67 and its clinical significance


Methods: The clinical pathological data of one hundred and sixteen invasive breast cancer patients who were admitted into our hospital from July 2013 to December 2015 and underwent radical mastectomy were retrospectively analyzed. The expression of topoispmerase [Topo] lla and Ki67 was detected using immunohistochemical method, and the correlation between the two kinds of proteins and the general clinical pathological characteristics of the patients was analyzed


Results: The positive expression rates of Topo Ha and Ki67 in breast cancer were 58.6% and 75% respectively


The expression of Topo lla was in no apparent correlation with the age, tumor size, estrogen receptor [ER], progesterone receptor [PR] and human epidermal growth factor receptor 2 [HER-2] [P>0.05], but in a correlation with the number of metastatic lymph glands [P<0.05]. The expression of Ki67 was in no apparent correlation with the age, tumor size, EP and HER-2, but in a correlation with the number of metastatic lymph glands and PR [P<0.05]. The multi-factor logistic regression analysis results suggested that the number of metastatic lymph glands was the independent predictive factor of Topo lla positive expression and the number of metastatic lymph glands and PR protein expression state are the independent predictive factors of Ki67 positive expression


Conclusion: Topo lla and Ki67 can be regarded as the indicators for reflecting the proliferation activity of tumor cells, and the detection of Topo lla and Ki67 expression is of great significance to the prognosis evaluation of breast cancer patients and clinical treatment


Subject(s)
Humans , Female , Adolescent , Adult , Middle Aged , Aged , Aged, 80 and over , Ki-67 Antigen , DNA Topoisomerases, Type I , Mastectomy, Radical , Immunohistochemistry , Logistic Models
11.
Fisioter. Bras ; 18(4): f:514-I:520, 2017.
Article in Portuguese | LILACS | ID: biblio-907065

ABSTRACT

O câncer de mama é a neoplasia de maior incidência entre as brasileiras. O tratamento padrão para o câncer de mama é composto por cirurgia conservadora. Disfunções provenientes do pós-operatório (PO) podem gerar prejuízos, nas relações familiares e sociais, o que pode interferir na qualidade de vida da mulher. A fisioterapia traz como objetivo minimizar o impacto negativo causado pelo câncer. Portanto, este estudo vem apresentar uma revisão sistemática sobre a atuação da fisioterapia no pós-operatório de câncer de mama, e discorrer sobre recursos fisioterapêutico utilizados no pós-operatório. Trata-se de um estudo realizado através de uma revisão bibliográf ca, na qual foram utilizados artigos de caráter científicos publicados nos últimos 10 anos nos banco de dados: Scielo, Lilacs, Medline, Bireme, Instituto Nacional do Câncer (INCA), Ministério da Saúde. Os resultados obtidos demonstraram que a fisioterapia contribui para a recuperação da mulher após submeterem-se à cirurgia, prevenindo e diminuindo o risco de complicações no PO de câncer de mama. A revisão bibliográfica evidenciou a importância da atuação fisioterapêutica, visando o tratamento integral e cuidados da paciente no PO de câncer de mama.(AU)


The breast cancer is the most common neoplasia between the Brazilian women, and the conservative surgery is considered the standard treatment. Post-operative dysfunctions can cause harm to familiar and social relationship, which can interfere in the women quality of life. The physical therapy aims to reduce the negative impact caused by the disease. Therefore, the present study is a systematic review about physical therapy performance on post operative breast cancer and verifies which physical therapy tools are used. This is a literature review which used scientific articles published in Portuguese in the last 10 years on the main electronic databases: Scielo, Lilacs, Medline, Bireme, National Institute of Cancer and Health Ministry. The results demonstrated that the physical therapy contributes to the women recovery after surgery, preventing and reducing the risk of complications in the post operative of breast cancer. The review evidenced the importance of the techniques used by Physical Therapists, aiming the integral treatment and cares to patients in post-operative of breast cancer.(AU)


Subject(s)
Humans , Female , Mastectomy, Radical , Postoperative Care , Breast Neoplasms , Physical Therapy Specialty , Review
12.
Rev. colomb. cancerol ; 20(4): 183-189, oct.-dic. 2016. ilus, tab
Article in Spanish | LILACS | ID: biblio-959869

ABSTRACT

De todas las neoplasias malignas de mama los carcinomas ductales son los más frecuentes. Menos del 5% son denaturaleza metaplásica y 0,04%-0,1% presentan diferenciación de células escamosas, subtipo que se considera más agresivo. Debido a los pocos casos en la literatura,no hay consenso sobre su diagnósticoy tratamiento. Presentamos tres casos con ese diagnóstico vistos entre 2014 y 2015 en nuestra institución y que corresponden a mujeres de 57, 49 y 65 años sin factores de riesgo y que presentaron cuadros clínicos similares consistentes con aparición de masa de crecimiento rápido. Dos de las pacientes se habían diagnosticado previamente con carcinoma ductal infiltrante de tipo no especial en biopsias por tru-cut con diagnóstico definitivo en la mastectomía radical que reportó en todos los casos carcinoma metaplásico escamoso confirmado por inmunohistoquímica.


Ductal carcinomas are the most common of all breast malignancies, less than 5% are of metaplastic nature, and 0.04% to 0.1% have squamous cell differentiation. These special subtypes are considered more aggressive. Due to the few cases in the literature, there is no consensus about its diagnosis and treatment. Three cases are presented with this diagnosis, seen in our institution between 2014 and 2015. They were women of 57, 49, and 65 years old with no risk factors, and who presented with similar clinical features, consisting of the appearance of a rapid growing mass. Two of the patients had been previously diagnosed with infiltrating ductal carcinoma of no special type by core needle biopsy, with a definitive diagnosis in radical mastectomy, which reported squamous metaplastic carcinoma confirmed by immunohistochemistry.


Subject(s)
Humans , Female , Middle Aged , Aged , Breast Neoplasms , Carcinoma, Squamous Cell , Mastectomy, Radical , Caribbean Region , Carcinoma, Ductal, Breast , Therapeutics , Risk Factors , Biopsy, Large-Core Needle
13.
Rev. chil. cir ; 68(1): 76-80, feb. 2016. ilus, tab
Article in Spanish | LILACS | ID: lil-780538

ABSTRACT

Abstract It is reported the case of a female patient 50 years old who, after failed attempts at diagnosis, arrives at breast surgery service of the E.S.E. Hospital Universitario del Caribe with history of five months consistent inthe excessive growth of a mass in right breast; patient received radical mastectomy plus reconstruction withlatissimus dorsi muscle flap. Following excision of tumor mass of 6,500 g is performed immunohistochemicaldiagnosis of a giant pleomorphic sarcoma.


Resumen introducción: Los tumores derivados del tejido conectivo interlobulillar de la mama son en mayor proporción malignos y, en virtud a su ubicación, en la actualidad reciben el nombre de "sarcomas" de la mama. Caso clínico: Se reporta el caso de una paciente femenina de 50 años de edad quien, posterior a fallidosintentos de diagnóstico, acude al servicio de cirugía de mama de la E.S.E. Hospital Universitario del Caribecon un cuadro de cinco meses de evolución consistente en el crecimiento desmedido de una masa en mamaderecha; la paciente recibió mastectomía radical más reconstrucción con colgajo de músculo dorsal ancho.Posterior a exéresis de masa tumoral de 6.500 g de peso se lleva a cabo diagnóstico inmunohistoquímico deun sarcoma pleomórfico gigante de la mama.


Subject(s)
Humans , Female , Middle Aged , Sarcoma/surgery , Breast Neoplasms/surgery , Sarcoma/pathology , Breast Neoplasms/pathology , Mastectomy, Radical
14.
rev. cuid. (Bucaramanga. 2010) ; 5(2): 842-850, july.-dic. 2014. tab
Article in Spanish | BDENF, LILACS | ID: lil-790053

ABSTRACT

Introducción: El cáncer de mama es una de las neoplasias más frecuentes en mujeres a nivel mundial y causan más muertes cada año. El diagnóstico oportuno es muy importante ya que es de relevancia en la elección y eficacia del tratamiento, teniendo mayor éxito cuando se detecta temprano. La mejor estrategia para la detección temprana es a través de la prevención primaria mediante información, orientación y educación a la población femenina acerca de los factores de riesgo y la promoción de conductas favorables a la salud. El objetivo del estudio fue identificar dominios y clases afectadas en paciente postoperada de mastectomía. Materiales y Métodos: Estudio de caso en paciente femenina de 47 años de edad diagnosticada con cáncer de mama izquierda, realizándole mastectomía radical izquierda en una institución de salud del sector privado de Tampico, Tamaulipas, México. Se aplicó el proceso enfermero, realizando la valoración de enfermería con la Taxonomía II de Diagnósticos de enfermería, se describen los dominios y clases afectadas en el periodo posoperatorio, implementándose el plan de cuidados de enfermería con las interrelaciones diagnósticos, intervenciones y resultados. Resultados: La paciente evolucionó favorablemente, egresando al tercer día de la intervención quirúrgica, se proporcionó educación para sus cuidados en el domicilio. Discusión y Conclusiones: Al finalizar la investigación del caso, se observó la importancia de llevar a cabo el plan de cuidados de enfermería con las respectivas interrelaciones para brindar atención de calidad.


Introduction: Breast cancer is one of the most common cancers in women worldwide and causes more deaths each year. Early diagnosis is very important because it is relevant in the choice and treatment efficacy, with greater success when caught early. The best strategy for early detection is through primary prevention through information, guidance and education to the female population about risk factors and promoting positive health behaviors. The aim of the study was to identify domains and affected classes in a postoperative mastectomy patient. Materials and Methods: A case study in female patients of 47 years of age diagnosed with left breast cancer, performing left radical mastectomy in a private health institution in Tampico, Tamaulipas, Mexico. The nursing process was applied, making the nursing assessment with Taxonomy II Nursing Diagnoses, domains and affected classes in the postoperative period are described, implementing the nursing care plan with interrelationships, diagnoses, interventions and outcomes. Results: The patient improved, egressing the third day after surgery, education was provided for care at home. Discussion and Conclusions: After investigating the case, the importance of carrying out the plan of nursing care with the respective relationships to provide quality care was observed.


Subject(s)
Humans , Female , Middle Aged , Postoperative Care/nursing , Mastectomy, Radical/nursing , Unilateral Breast Neoplasms/diagnosis , Mastectomy, Radical/psychology , Unilateral Breast Neoplasms/psychology
15.
Chinese Journal of Burns ; (6): 421-423, 2015.
Article in Chinese | WPRIM | ID: wpr-327379

ABSTRACT

<p><b>OBJECTIVE</b>To explore the clinical effects of ipsilateral lower trapezius myocutaneous flap for repairing cervical ulcer as a result of radiotherapy after radical mastectomy.</p><p><b>METHODS</b>Six patients with cervical ulcers as a result of radiotherapy after radical mastectomy were hospitalized from March 2010 to February 2015, suffering from persistent pain in different degrees. The wound area ranged from 6 cm × 4 cm to 10 cm × 6 cm before debridement, 8 cm × 5 cm to 16 cm × 10 cm after debridement. Ipsilateral lower trapezius myocutaneous flap was used to repair the wound after thorough debridement, with the area ranging from 10 cm × 7 cm to 20 cm × 13 cm. The donor sites were sutured directly or covered with medium-thickness skin graft obtained from the back.</p><p><b>RESULTS</b>Pain was obviously relieved in all the patients 2 days after surgery. The wounds in five patients were healed, while necrosis of superficial skin approximately 1 cm in diameter appeared at the distal end of one myocutaneous flap, and it healed after dressing change. During the follow-up period of 3 to 18 months, no recurrence of ulcer was found, the texture of the myocutaneous flaps was soft with good appearance, and the donor sites healed well.</p><p><b>CONCLUSIONS</b>On the basis of thorough debridement, it is feasible to repair the cervical ulcer as a result of radiotherapy after radical mastectomy with the ipsilateral lower trapezius myocutaneous flap.</p>


Subject(s)
Humans , Breast Neoplasms , Radiotherapy , General Surgery , Debridement , Mastectomy, Radical , Methods , Myocutaneous Flap , Neck Injuries , General Surgery , Necrosis , Pressure Ulcer , General Surgery , Plastic Surgery Procedures , Methods , Skin , Skin Transplantation , Superficial Back Muscles , Surgical Flaps , Wound Healing
16.
Chinese Journal of Oncology ; (12): 382-385, 2014.
Article in Chinese | WPRIM | ID: wpr-328932

ABSTRACT

<p><b>OBJECTIVE</b>To analyze the characteristics of lymph node metastasis and prognosis in patients with T1 breast cancer.</p><p><b>METHODS</b>The clinicopathological data of 354 patients with T1 breast cancer after standard treatment from March 2007 to September 2011 were collected to analyze the relationship between the clinical characteristics of T1 breast cancer, lymph node metastasis and prognostic features.</p><p><b>RESULTS</b>In the 354 patients with T1 breast cancer, 105 patients (29.7%) had lymph node metastasis, among them 73 cases (69.5%) had 1-3 lymph node metastasis, and 32 cases (30.5%) had more than 4 lymph node metastasis. The lymph node metastasis rate was 8.3% in T1a patients, 39.7% in T1b patients, and 30.4% in T1c cases (P = 0.005). Pairwise comparison showed that the difference of lymph node metastasis rate between T1a, T1b and T1c patients was statistically significant (P = 0.001 and P = 0.006, respectively). The difference of lymph node metastasis rates in T1b and T1c patients was statistically insignificant (P = 0.171). In the 354 patients of T1 breast cancer, 92 patients had vascular tumor thrombi and their lymph node metastasis rate was 71.7%, while the lymph node metastasis rate in 262 patients without vascular tumor thrombus was 14.9% (P < 0.001). The median follow-up was 49 months (range 27-81 months). 12 patients developed recurrence, and 3 patients died, one of them died of cerebrovascular accident. The 4-year disease-free survival for all patients was 96.6%, and the 4-year overall survival rate was 99.2%.</p><p><b>CONCLUSIONS</b>There is a correlation between vascular tumor thrombus, tumor size and lymph node metastasis rate. The lymph node metastasis rate is lower in T1a patients and relatively higher in T1b/c patients. Compared with patients without vascular tumor thrombus, the T1 breast cancer patients with vascular tumor thrombi have a higher lymph node metastasis rate. Generally speaking, there is a still good prognosis in patients with T1 breast cancer.</p>


Subject(s)
Adult , Aged , Female , Humans , Middle Aged , Young Adult , Antineoplastic Combined Chemotherapy Protocols , Therapeutic Uses , Breast Neoplasms , Drug Therapy , Pathology , General Surgery , Carcinoma, Ductal, Breast , Drug Therapy , Pathology , General Surgery , Carcinoma, Lobular , Drug Therapy , Pathology , General Surgery , Disease-Free Survival , Follow-Up Studies , Lymphatic Metastasis , Mastectomy, Radical , Neoplasm Recurrence, Local , Neoplasm Staging , Neoplastic Cells, Circulating , Prognosis , Survival Rate
17.
Journal of Breast Cancer ; : 202-207, 2013.
Article in English | WPRIM | ID: wpr-38436

ABSTRACT

PURPOSE: Metastatic status of internal mammary lymph node (IMLN) has a clinical importance in assessing the stage and prognosis of breast cancer. But, when metastasis of IMLN is suspected; the management is controversial. We retrospectively reviewed 36 breast cancer patients who underwent IMLN biopsy, and investigated the pathologic status of IMLN which suspected metastasis with positron emission tomography and computed tomography (PET/CT). METHODS: From January 2007 to December 2012, 36 patients underwent IMLN biopsy for suspected IMLN metastasis on PET/CT, when diagnosed with primary or recurrent breast cancer. Clinicopathologic features of these patients and metastatic status of IMLNs were investigated. RESULTS: A total of 36 patients were included in this study. Twenty-four patients diagnosed with primary breast cancer and 12 patients diagnosed with recurrent breast cancer underwent IMLN biopsy. The mean number of IMLNs was 2.72+/-2.05, and the total metastatic rate of IMLNs was 72.2% (26 out of 36). IMLN metastasis was confirmed on pathologic examination in 19 patients (79.2%, 19 out of 24) with primary breast cancer and in 7 patients (58.3%, 7 out of 12) with recurrent breast cancer. The mean standardized uptake values of metastatic and nonmetastatic IMLNs in primary breast cancer were 3.50+/-2.51 and 3.72+/-3.55, respectively and those of metastatic and nonmetastatic IMLN in recurrent breast cancer were 3.92+/-2.67 and 4.12+/-3.57, respectively. In both groups, there was no statistically significant difference between the SUVs of metastatic and nonmetastatic IMLNs (p=0.291 and p=0.951, respectively). CONCLUSION: Due to the recent advances in diagnostic and surgical skills, IMLN biopsy can be performed safely without any complications without performing radical mastectomy. If IMLN metastasis is suspected on PET/CT, IMLN biopsy is useful to assess the exact stage and to determine the treatment for breast cancer. Further follow-up studies are needed to assess the locoregional recurrence and to compare the improvement in overall survival and disease-free survival.


Subject(s)
Humans , Biopsy , Breast Neoplasms , Disease-Free Survival , Follow-Up Studies , Lymph Nodes , Mastectomy, Radical , Neoplasm Metastasis , Positron Emission Tomography Computed Tomography , Prognosis , Recurrence , Retrospective Studies
18.
Chinese Journal of Oncology ; (12): 936-940, 2013.
Article in Chinese | WPRIM | ID: wpr-329013

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the effect of low-dose carvedilol combined with candesartan in the prevention of acute and chronic cardiotoxicity of anthracycline drugs in adjuvant chemotherapy of breast cancer.</p><p><b>METHODS</b>Forty patients were randomly divided into two groups: the experimental group with chemotherapy plus low-dose carvedilol combined with candesartan (20 cases) and control group with chemotherapy alone (20 cases). The same chemotherapy was given to the two groups. All the 40 patients had no contraindication for carvedilol and candesartan. Patients of the experimental group received low-dose carvedilol from 2.5 mg orally twice a day at first cycle to 5 mg twice a day gradually if no side reactions, and candesartan 2.5 mg orally once a day. Electrocardiogram, ultrasonic cardiogram, arrhythmia, troponin and non-hematologic toxicity were recorded and compared after the second, forth and sixth cycle of chemotherapy. Each cycle included 21 days.</p><p><b>RESULTS</b>LVEF was decreased along with the prolongation of chemotherapy in the experimental group and control group. LVEDD and LVESD showed no significant changes in the experimental group, but gradually increased in the control group. After four and six cycles of chemotherapy, LVEF were (57.00 ± 5.13)% and (45.95 ± 3.68)%, respectively, in the control group, significantly lower than that of (67.00 ± 5.13)% and (57.50 ± 2.57)%, respectively, in the experimental group (P < 0.05). After six cycles of chemotherapy, LVEDD and LVESD were (50.00 ± 10.48) mm and (35.01 ± 2.99) mm, respectively, in the control group, significantly higher than those before chemotherapy (P < 0.05) and experimental group (P < 0.001). The rate of ST segment and T wave abnormalities was 80.0% in the control group after six cycles of chemotherapy, significantly higher than that of 25.0% after four cycles of chemotherapy (P = 0.001) and 10.0% after two cycles of chemotherapy (P < 0.001). The reduction of QRS voltage, arrhythmia and abnormal troponin were 55.0%, 45.0% and 45.0%, respectively, in the control group, significantly higher than those in the experimental group (20.0%, P < 0.05), (10.0%, P = 0.010) and (10.0%, P < 0.05), respectively. The rate of abnormal expression of troponin was 45.0% in the control group, significantly higher than the 10.0% in the experimental group (P < 0.05).</p><p><b>CONCLUSIONS</b>The use of low-dose carvedilol combined with candesartan can reduce the acute and chronic cardiotoxicity of anthracycline drugs, and with tolerable toxicities. This may provide a new approach to prevent cardiotoxicity of anthracycline drugs in adjuvant chemotherapy of breast cancer.</p>


Subject(s)
Adult , Aged , Female , Humans , Middle Aged , Adrenergic beta-Antagonists , Pharmacology , Angiotensin II Type 1 Receptor Blockers , Pharmacology , Antineoplastic Combined Chemotherapy Protocols , Therapeutic Uses , Arrhythmias, Cardiac , Benzimidazoles , Pharmacology , Breast Neoplasms , Drug Therapy , General Surgery , Carbazoles , Pharmacology , Chemotherapy, Adjuvant , Cyclophosphamide , Therapeutic Uses , Electrocardiography , Epirubicin , Therapeutic Uses , Fluorouracil , Therapeutic Uses , Mastectomy, Radical , Propanolamines , Pharmacology , Stroke Volume , Tetrazoles , Pharmacology , Troponin , Metabolism
19.
Chinese Journal of Oncology ; (12): 525-529, 2013.
Article in Chinese | WPRIM | ID: wpr-267506

ABSTRACT

<p><b>OBJECTIVE</b>Pure epithelial breast metaplastic carcinoma is a rare and highly malignant tumor. In this study, our purpose was to analyze the clinical features, treatment method and prognostic factors, so to explore the approach for early diagnosis and appropriate treatment of this cancer.</p><p><b>METHODS</b>Clinical data of 22 patients with histopathologically confirmed pure epithelial breast metaplastic carcinoma and treated at Tianjin Cancer Hospital from 1974 to 2008, were reviewed retrospectively. Survival rate was calculated by life tables. Kaplan-Meier unvariate analysis and Log-rank test were used to compare the survival rates. Multivariate factors for survival were analyzed by Cox proportional hazards regression model.</p><p><b>RESULTS</b>The median age of the 22 cases of pure epithelial breast metaplastic carcinoma was 52.5 years. Among them 20 cases went to see a doctor for painless mass, and two cases shown as skin inflammation. Clarifying a diagnosis was difficult before operation so that its diagnosis mainly depended on postoperative histopathologic examination. Twelve cases had axillary lymph node metastasis, 7 cases distant metastasis, and the lung was the most common metastatic organ. The 5-year survival rate was 55.6%, with a median follow-up of 46 months. It was found by Kaplan-Meier unvariate analysis that the age (P = 0.044), number of positive axillary lymph nodes (P = 0.011) and therapeutic schedule (P = 0,003) significantly influenced the outcome of the patients, but tumor size (P = 0.194) was not. Cox multivariate analysis results showed that number of positive axillary lymph nodes was independent prognostic factor for pure epithelial breast metaplastic carcinoma (P = 0.038).</p><p><b>CONCLUSIONS</b>Pure epithelial breast metaplastic carcinoma is seldom seen. It is easy to cause distant metastasis and has a poor prognosis. ER, PR and HER-2 expressions in most samples are negative. The more axillary lymph nodes have metastasis, the poorer is the prognosis. A reasonable and comprehensive treatment can improve the prognosis obviously.</p>


Subject(s)
Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Axilla , Breast Neoplasms , Drug Therapy , Pathology , Radiotherapy , General Surgery , Carcinoma , Drug Therapy , Pathology , Radiotherapy , General Surgery , Carcinoma, Adenosquamous , Drug Therapy , Pathology , Radiotherapy , General Surgery , Carcinoma, Squamous Cell , Drug Therapy , Pathology , Radiotherapy , General Surgery , Chemotherapy, Adjuvant , Follow-Up Studies , Lung Neoplasms , Lymph Node Excision , Lymph Nodes , Pathology , Lymphatic Metastasis , Mastectomy, Radical , Methods , Proportional Hazards Models , Retrospective Studies , Survival Rate
20.
Article in English | IMSEAR | ID: sea-157443

ABSTRACT

Aims and Objectives: 1) To study the incidence of various neoplastic lesions of breast. 2) To study the histopathological features of neoplasms and classify them according to WHO classification (2003). 3) To compare the results of study with those of other studies. Materials and Methods: The present study was prospective as well as retrospective which include 252 cases from October 2005 to October 2010. The specimens were received in different forms such as excisional biopsies, modified radical mastectomies, simple mastectomies, tru-cut biopsies, wide local excision and quadrantectomy specimens. Detail gross examination was done for each specimen and histopathological features were studied to classify neoplasms according to WHO classification 2003. Results: Out of total 9086 biopsies, breast biopsies were 366 (4%) during this 5 year study. Total 252 breast neoplasms were studied, where, the incidence of benign neoplasms was 50.4% (127 cases) & for malignant neoplasms was 49.6% (125 cases). Among all types of specimen received, excision biopsy was most common (48%). Upper outer quadrant was most commonly involved region for breast neoplasms. Fibroadenoma, benign phyllodes neoplasm, tubular adenoma, central papilloma, peripheral papilloma, lipoma and neurofibroma were seen among benign neoplasms. While invasive ductal carcinoma not otherwise specified, mixed carcinoma, metaplastic carcinoma, mucinous carcinoma, malignant phyllodes neoplasm, invasive lobular carcinoma, invasive papillary carcinoma, medullary carcinoma, intracystic papillary carcinoma, malignant peripheral nerve sheath neoplasm and collision neoplasm were studied among malignant neoplasms. The most common benign neoplasm was fibroadenoma (87%) and invasive ductal carcinoma not otherwise specified (88%) was malignant neoplasm. Conclusions: Fibroadenoma was the most common (87%) benign breast neoplasm. Among all malignant breast neoplasms, invasive ductal carcinoma, not otherwise specified was most common (88%). In cases of benign neoplasms, the highest incidence was found in the age group of 10-20 years (37%) while in the malignant neoplasms, it was 40 - 60 years (51.2%). The incidence of malignant breast neoplasm in male was 2.4%.


Subject(s)
Adult , Breast Neoplasms/classification , Breast Neoplasms/diagnosis , Breast Neoplasms/epidemiology , Breast Neoplasms/pathology , Breast Neoplasms, Male/classification , Breast Neoplasms, Male/diagnosis , Breast Neoplasms, Male/epidemiology , Breast Neoplasms, Male/pathology , Child , Female , Fibroadenoma/classification , Fibroadenoma/diagnosis , Fibroadenoma/epidemiology , Fibroadenoma/pathology , Humans , Male , Mastectomy, Radical , Middle Aged , World Health Organization , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL